Scientists built humanized antibody mice in 8 weeks instead of over a year

Key Findings

💉 A Gentler Path to Stem Cell Transplants

• Chemotherapy and radiation before stem cell transplants carry serious long-term risks. Researchers used base editing and prime editing to alter a surface protein on donor stem cells so that antibody-based conditioning drugs could clear the patient's existing blood cells without destroying the transplanted ones.
• In animal models, edited cells progressively took over blood production under antibody treatment — reaching therapeutic levels for sickle cell disease and beta-thalassemia — without signs of dangerous clonal expansion.

🧪 Mapping Which Histone Marks Actually Matter in Mammals

• Histones are the protein spools DNA wraps around, and chemical tags on specific amino acids control which genes get read. The problem: mammals have dozens of near-identical histone gene copies, making it hard to test what each tag does. This team built a high-throughput prime editing platform to mutate all copies simultaneously in mouse stem cells.
• Key residues — including H3K4, H3K9, H3K14, H3K18, and H3K79 — proved essential for cell survival. Combining mutations at H3K27 and H3K36 together impaired stem cell self-renewal in ways neither mutation caused alone.

🧠 Parkinson's Cell Therapy Holds Up in Primates Over 18 Months

• Researchers transplanted dopamine-producing cell precursors — derived from a Parkinson's patient and gene-corrected with CRISPR — into the brains of monkeys with chemically induced Parkinson's. After 18 months, grafted cells survived, matured, and restored dopamine synthesis as measured by PET imaging.
• Motor improvements were sustained in both the gene-corrected and uncorrected mutant cell groups, with no tumor formation or abnormal immune response observed.

🌱 Glyphosate-Resistant Watermelon, No Transgenes Required

• Using prime editing, researchers altered a single watermelon gene involved in herbicide sensitivity, producing plants that tolerate field-level glyphosate doses without growth penalties.
• Critically, the edited plants are classified as non-transgenic — no foreign DNA was introduced — which has significant implications for regulatory approval in many countries. The heterozygous mutant lines are designed as parental stock for conventional breeding programs.

❤️ A Lab-Grown Heart Model Catches a Rare Arrhythmia Drug Response

• Short QT syndrome is a rare inherited heart rhythm disorder with no established optimal treatment. Researchers used prime editing to introduce the disease-causing mutation into a normal human stem cell line, then grew those cells into beating heart muscle cells for drug testing.
• The isogenic model — genetically identical except for the single mutation — confirmed a shortened electrical signal consistent with the syndrome, and showed that quinidine prolonged it, matching limited clinical observations. Chloroquine prolonged the signal but also triggered irregular beats.

🦠 A Metabolic Switch Linked to Gastric Cancer Spread

• A CRISPR-based screen across metabolic genes identified a mitochondrial enzyme called ALDH6A1 as a suppressor of cancer invasion in gastric tumors. When the enzyme's activity dropped, a metabolite called methylmalonic acid accumulated and interfered with a gene-silencing protein, increasing activity of invasion-promoting genes including one that drives blood vessel growth.
• In mice, pharmacologically activating ALDH6A1 or clearing the accumulated metabolite reduced metastatic spread to the liver.